Article

Katena, IOP Ophthalmics combine

Katena has announced its acquisition of IOP Ophthalmics of Costa Mesa, CA.

 

Denville, NJ-Katena has announced its acquisition of IOP Ophthalmics of Costa Mesa, CA.

Terms of the transaction have not been disclosed.

IOP Ophthalmics-a company that develops, commercializes, and distributes specialty ophthalmic surgical devices and biologics-holds market leadership positions with amniotic membrane technologies for ocular surface, glaucoma, and oculoplastic indications; devices for glaucoma and oculoplastic indications; and bioimplants for general ophthalmic surgeries.

“This combination of two great companies not only creates greater critical mass in the ophthalmology marketplace, but it enhances our ability to provide more clinical solutions and be of greater value to our customers,” said Bill Friedberg, president and chief executive officer of Katena.

Jason Malecka, president and founder of IOP-along with Erich Ziegler, vice president and chief financial officer of IOP-will continue their relationship with the combined company, and will continue in their roles focusing on global product growth.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.